1. Home
  2. TVTX vs EXPI Comparison

TVTX vs EXPI Comparison

Compare TVTX & EXPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • EXPI
  • Stock Information
  • Founded
  • TVTX 2008
  • EXPI 2008
  • Country
  • TVTX United States
  • EXPI United States
  • Employees
  • TVTX N/A
  • EXPI N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • EXPI Real Estate
  • Sector
  • TVTX Health Care
  • EXPI Finance
  • Exchange
  • TVTX Nasdaq
  • EXPI Nasdaq
  • Market Cap
  • TVTX 1.5B
  • EXPI 1.6B
  • IPO Year
  • TVTX N/A
  • EXPI N/A
  • Fundamental
  • Price
  • TVTX $17.92
  • EXPI $11.01
  • Analyst Decision
  • TVTX Strong Buy
  • EXPI Strong Buy
  • Analyst Count
  • TVTX 16
  • EXPI 1
  • Target Price
  • TVTX $33.40
  • EXPI $12.00
  • AVG Volume (30 Days)
  • TVTX 1.5M
  • EXPI 1.0M
  • Earning Date
  • TVTX 08-06-2025
  • EXPI 07-31-2025
  • Dividend Yield
  • TVTX N/A
  • EXPI 1.82%
  • EPS Growth
  • TVTX N/A
  • EXPI N/A
  • EPS
  • TVTX N/A
  • EXPI N/A
  • Revenue
  • TVTX $333,865,000.00
  • EXPI $4,593,157,000.00
  • Revenue This Year
  • TVTX $71.61
  • EXPI $3.60
  • Revenue Next Year
  • TVTX $43.45
  • EXPI $4.71
  • P/E Ratio
  • TVTX N/A
  • EXPI N/A
  • Revenue Growth
  • TVTX 87.94
  • EXPI 3.62
  • 52 Week Low
  • TVTX $8.46
  • EXPI $6.90
  • 52 Week High
  • TVTX $25.29
  • EXPI $15.39
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 59.60
  • EXPI 61.19
  • Support Level
  • TVTX $17.24
  • EXPI $10.00
  • Resistance Level
  • TVTX $19.08
  • EXPI $10.70
  • Average True Range (ATR)
  • TVTX 0.87
  • EXPI 0.40
  • MACD
  • TVTX 0.04
  • EXPI 0.00
  • Stochastic Oscillator
  • TVTX 66.67
  • EXPI 97.69

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.

Share on Social Networks: